LifeStance HealthNASDAQ: LFST

Election stress is contributing to an increase in anxiety and strained relationships, reinforcing the importance of accessible mental healthcare  SCOTTSDALE, Ariz. , Oct. 8, 2024 /PRNewswire/ -- A LifeStance Health survey released today reveals how widespread election-related anxiety is impacting Americans' mental health, straining their personal relationships and prompting many to limit social media exposure.

TORONTO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support human wellness in innovative ways, is pleased to report that, further to its news release dated June 25, 2024, it has completed the sale today of the shares (the “Closing”) of CannMart Inc. (“CannMart”), a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards, to Simply Solventless Concentrates Ltd.

The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

TORONTO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc.(TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF) My Fellow Shareholders, Further to my previous letter of August 15, 2024, we wish to remind you of the reasoning behind the strategic decision to divest Lifeist of CannMart Inc. (“CannMart”) via a sale to Simply Solventless Concentrates Ltd. (“SSC”) per our press release of June 25, 2024, and why shareholders should vote in favor of the transaction at the Annual and Special Meeting on September 5, 2024.

LFST has a strong value proposition for patients and is well-positioned to grow due to the increasing demand for mental health services in the US. Recent positive financial results show improved revenue and adj EBITDA margins, giving confidence in LFST's ability to achieve double-digit margins by FY25. The hybrid model of in-person and telehealth services provides advantages for both patients and LFST, leading to increased patient adoption and potential for continued growth.

TORONTO, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to report that it has completed, pursuant to a share purchase agreement entered into on August 16, 2024 with an arm's length party, the acquisition of the shares of 1000594871 Ontario Corp. (“4871”) which holds key intellectual property resulting from a patent application and all rights thereto.

TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc.(TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF) My Fellow Shareholders, In response to inquiries from many of you, we wish to set forth the reasoning behind the strategic decision to divest Lifeist of CannMart Inc. (“CannMart”) via a sale to Simply Solventless Concentrates Ltd. (“SSC”) under the terms of the agreement set forth in our press release of June 25, 2024.

The mean of analysts' price targets for LifeStance Health (LFST) points to a 39.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

LifeStance Health Group (LFST) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.13 per share a year ago.